Clinical Trial Update: Nucleoside Therapy in Patients With Telomere Biology Disorders [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating nucleoside therapy in patients with telomere biology disorders is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyskeratosis Congenita
• Familial Pulmonary Fibrosis
• Hoyeraal-hreidarsson Syndrome
• Interstitial Lung Disease Due to Systemic Disease Associated with Telomere Biology Disorders
• Revesz Syndrome
• Telomere Biology Disorders
• Telomere Biology Disorders with Bone Marrow Failure

Drugs mentioned

• Nucleoside therapy

Snippet

Sponsor: Suneet Agarwal | Conditions: Telomere Biology Disorders, Dyskeratosis Congenita | Phase 1 | Status: RECRUITING